Literature DB >> 9661589

Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures.

B Ettinger1, A Pressman, P Sklarin, D C Bauer, J A Cauley, S R Cummings.   

Abstract

To evaluate the skeletal effects of endogenous serum estradiol, we measured bone mineral density (BMD) at the calcaneus and radius (single photon absorptiometry) and at the hip and spine (dual x-ray absorptiometry) in 274 women aged 65 yr or more who participated in the Study of Osteoporotic Fractures. Lateral radiographs of the thoracic and lumbar spine were also taken, and serum was assayed for estradiol. Those who had estradiol levels from 10-25 pg/mL had 4.9%, 9.6%, 7.3%, and 6.8% greater BMD at total hip, calcaneus, proximal radius, and spine than those with levels below 5 pg/mL. After multiple adjustments, BMD differences remained statistically significant and corresponded to about 0.4 SD. Vertebral deformities were less prevalent among women whose estradiol level exceeded 5 pg/mL; the multiple adjusted odds ratio was 0.4 (95% confidence interval, 0.2-0.8). We conclude that physiologically low estradiol has a salutary effect on the skeleton in elderly women, possibly by reducing skeletal remodeling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661589     DOI: 10.1210/jcem.83.7.4708

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

1.  Estrogen prevents the reduction in fractional calcium absorption due to energy restriction in mature rats.

Authors:  Mariana Cifuentes; Juan P Advis; Sue A Shapses
Journal:  J Nutr       Date:  2004-08       Impact factor: 4.798

2.  Optimizing bone health in anorexia nervosa and hypothalamic amenorrhea: new trials and tribulations.

Authors:  Joo-Pin Foo; Ole-Petter R Hamnvik; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-01-31       Impact factor: 8.694

3.  Combination of automatic HPLC-RIA method for determination of estrone and estradiol in serum.

Authors:  T Yasui; M Yamada; H Kinoshita; H Uemura; N Yoneda; M Irahara; T Aono; S Sunahara; Y Mito; F Kurimoto; K Hata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Burden of pelvis fracture: a population-based study of incidence, hospitalisation and mortality.

Authors:  D Prieto-Alhambra; F F Avilés; A Judge; T Van Staa; X Nogués; N K Arden; A Díez-Pérez; C Cooper; M K Javaid
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

5.  Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.

Authors:  Fatima Nayeem; Nai-Wei Chen; Manubai Nagamani; Karl E Anderson; Lee-Jane W Lu
Journal:  Nutr Res       Date:  2019-07-03       Impact factor: 3.315

6.  Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Authors:  Irene Lambrinoudaki; George Christodoulakos; Leon Aravantinos; Aristidis Antoniou; Demetrios Rizos; Constantinos Chondros; Apostolos Kountouris; Grigorios Chrysofakis; George Creatsas
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 7.  Elevated bone mass: a weighty matter?

Authors:  William D Leslie
Journal:  Skeletal Radiol       Date:  2008-12       Impact factor: 2.199

8.  Bone: serotonin, leptin and the central control of bone remodeling.

Authors:  Clifford J Rosen
Journal:  Nat Rev Rheumatol       Date:  2009-12       Impact factor: 20.543

9.  A coupled mechano-biochemical model for bone adaptation.

Authors:  Václav Klika; Maria Angelés Pérez; José Manuel García-Aznar; František Maršík; Manuel Doblaré
Journal:  J Math Biol       Date:  2013-11-12       Impact factor: 2.259

Review 10.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.